Open-Label Placebo for Functional Dyspepsia

Beth Israel Lahey Health

Status and phase: Terminated; Early Phase 1

Conditions: Dyspepsia

Treatments: Drug: Placebos

Study type: Interventional

Funder types: Other

Identifiers

NCT03745781

2018P000294

Details and patient eligibility

About

The study is evaluating the efficacy of open-label placebo for the treatment of functional dyspepsia.

Enrollment: 21 patients

Sex: All

Ages: 18 to 80 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Functional Dyspepsia

Exclusion criteria

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: None (Open label)

---

21 participants in 2 patient groups

open-label placebo

Experimental group

Description:

open-label placebo

Treatment:

Drug: Placebos

treatment as usual

No Intervention group